Literature DB >> 26421971

The Need for Vigilance in the Marketing of Genomic Tests in Psychiatry.

Robert Klitzman1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26421971      PMCID: PMC4610007          DOI: 10.1097/NMD.0000000000000372

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  12 in total

1.  Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients.

Authors:  A Serretti; M Kato; D De Ronchi; T Kinoshita
Journal:  Mol Psychiatry       Date:  2006-12-05       Impact factor: 15.992

Review 2.  Antidepressant pharmacogenetics.

Authors:  Ajeet B Singh; Chad A Bousman; Chee Ng; Michael Berk
Journal:  Curr Opin Psychiatry       Date:  2014-01       Impact factor: 4.741

Review 3.  Psychiatric genetics: progress amid controversy.

Authors:  Margit Burmeister; Melvin G McInnis; Sebastian Zöllner
Journal:  Nat Rev Genet       Date:  2008-07       Impact factor: 53.242

4.  Clinical efficacy data on gene tests trails marketing in psychiatry.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2012-08       Impact factor: 53.440

5.  Views of internists towards uses of PGD.

Authors:  Robert Klitzman; Wendy Chung; Karen Marder; Anita Shanmugham; Lisa J Chin; Meredith Stark; Cheng-Shiun Leu; Paul S Appelbaum
Journal:  Reprod Biomed Online       Date:  2012-11-21       Impact factor: 3.828

Review 6.  The AmpliChip: A Review of its Analytic and Clinical Validity and Clinical Utility.

Authors:  Spencer B Chau; Roger E Thomas
Journal:  Curr Drug Saf       Date:  2015

7.  Genome-wide association study of antidepressant treatment-emergent suicidal ideation.

Authors:  Andreas Menke; Katharina Domschke; Darina Czamara; Torsten Klengel; Johannes Hennings; Susanne Lucae; Bernhard T Baune; Volker Arolt; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

Review 8.  Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.

Authors:  Catalina Betancur
Journal:  Brain Res       Date:  2010-12-01       Impact factor: 3.252

9.  Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training.

Authors:  Melissa Salm; Kristopher Abbate; Paul Appelbaum; Ruth Ottman; Wendy Chung; Karen Marder; Cheng-Shiun Leu; Roy Alcalay; Jill Goldman; Alexander Malik Curtis; Christopher Leech; Katherine Johansen Taber; Robert Klitzman
Journal:  J Genet Couns       Date:  2013-06-21       Impact factor: 2.537

Review 10.  Pharmacogenetics in psychiatry: translating research into clinical practice.

Authors:  A K Malhotra; J-P Zhang; T Lencz
Journal:  Mol Psychiatry       Date:  2011-11-15       Impact factor: 15.992

View more
  3 in total

1.  Integrating Genomics into Psychiatric Practice: Ethical and Legal Challenges for Clinicians.

Authors:  Eric T Ward; Kristin M Kostick; Gabriel Lázaro-Muñoz
Journal:  Harv Rev Psychiatry       Date:  2019 Jan/Feb       Impact factor: 3.732

2.  Roles of genetics and blood type in clinical responses to COVID-19: ethical and policy concerns.

Authors:  Robert Klitzman
Journal:  J Med Ethics       Date:  2020-12-09       Impact factor: 2.903

3.  Gatekeepers for infertility treatment? Views of ART providers concerning referrals by non-ART providers.

Authors:  Robert Klitzman
Journal:  Reprod Biomed Soc Online       Date:  2017-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.